Header cover image

Indian (NIFTY) Life Sciences Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies13
  • 7D2.1%
  • 3M0.4%
  • 1Y31.9%
  • YTD21.9%

Over the last 7 days, the Life Sciences industry has risen 2.1%, driven by gains from Divi's Laboratories of 3.2%. This takes the industry's 12 month performance to a gain of 32%.

Industry Valuation and Performance

Has the Indian Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021₹1.7t₹137.6b₹24.4b31.7x
Tue, 26 Oct 2021₹1.6t₹132.2b₹22.8b20.1x
Thu, 23 Sep 2021₹1.7t₹131.1b₹22.9b23.7x
Sat, 21 Aug 2021₹1.6t₹131.4b₹22.9b23.3x
Sat, 05 Jun 2021₹1.4t₹121.4b₹21.5b39.6x
Tue, 09 Mar 2021₹1.2t₹116.0b₹22.4b45x
Mon, 30 Nov 2020₹1.2t₹114.7b₹22.2b28.8x
Thu, 03 Sep 2020₹1.1t₹116.1b₹19.8b49.6x
Sun, 07 Jun 2020₹795.2b₹116.7b₹17.2b28.2x
Sat, 29 Feb 2020₹702.9b₹101.6b₹18.5b30.3x
Tue, 03 Dec 2019₹666.1b₹104.8b₹20.4b27.3x
Fri, 06 Sep 2019₹618.8b₹101.2b₹19.9b31.8x
Mon, 10 Jun 2019₹637.3b₹95.3b₹18.8b31.2x
Sun, 03 Mar 2019₹623.5b₹85.2b₹15.3b21.7x
Wed, 05 Dec 2018₹566.7b₹84.3b₹15.1b23.3x
PE Ratio

23.3x

Total Market Cap: ₹566.7bTotal Earnings: ₹15.1bTotal Revenue: ₹84.3b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 31.5x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Life Sciences industry have grown 17% per year over the last three years, and revenues for these companies have grown 18% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Life Sciences industry?

Clinical Research and Equipment2.08%

Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry, which is trading close to its 3-year average PE ratio of 31.5x. This is likely because analysts are expecting annual earnings growth of 22%, which is higher than its past year's earnings growth of 18% per year.

Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 22% over the next 5 years. This is better than it's past earnings growth rate of 18% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
DIVISLAB Divi's Laboratories3.2%+₹40.4b37.0%PE61.4x
538837 Jeevan Scientific Technology29.5%+₹469.8m314.2%PE12.4x
524394 Vimta Labs4.2%+₹338.2m181.6%PE25x
540701 Dishman Carbogen Amcis0.3%+₹94.1m58.1%PS1.8x
511509 Vivo Bio Tech1.5%+₹13.5m33.7%PE21.8x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News